Tryptophan 2,3-dioxygenase (TDO), a liver-specific cytosolic hemoprotein, is the rate-limiting enzyme in L-tryptophan catabolism and thus a key serotonergic determinant. Glucocorticoids transcriptionally activate the TDO gene with marked enzyme induction. TDO is also regulated by heme, its prosthetic moiety, as its expression and function are significantly reduced after acute hepatic heme depletion. Here we show in primary rat hepatocytes that this impairment is not due to faulty transcriptional activation of the TDO gene but rather due to its posttranscriptional regulation by heme. Accordingly, in acutely heme-depleted hepatocytes, the de novo synthesis of TDO protein is markedly decreased (Ͼ90%) along with that of other hepatic proteins. This global suppression of de novo hepatic protein syntheses in these heme-depleted cells is associated with a significantly enhanced phosphorylation of the ␣-subunit of the eukaryotic initiation factor eIF2 (eIF2␣), as monitored by the phosphorylated eIF2␣/total eIF2␣ ratio. Heme supplementation reversed these effects, indicating that heme regulates TDO induction by functional control of an eIF2␣ kinase. A cDNA was cloned from heme-depleted rat hepatocytes, and DNA sequencing verified its identity to the previously cloned rat brain heme-regulated inhibitor (HRI). Proteomic, biochemical, and/or immunoblotting analyses of the purified recombinant protein and the immunoaffinity-captured hepatic protein confirmed its identity as a rat heme-sensitive eIF2␣ kinase. These findings not only document that a hepatic HRI exists and is physiologically relevant but also implicate its translational shut-off of key proteins in the pathogenesis and symptomatology of the acute hepatic heme-deficient conditions clinically known as the hepatic porphyrias.
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Tryptophan 2,3-dioxygenase (TDO) is a liver-specific cytosolic enzyme highly specific for L-tryptophan (L-Trp) as the substrate (Greengard and Feigelson, 1961; Schimke et al., 1965; Knox, 1966) . As the rate-limiting enzyme in L-Trp oxidative breakdown to kynurenine, its activity critically determines the relative L-Trp flux into serotonergic (5-HT) and kynurenine [NAD, NADP, poly(ADP-ribose)] pathways (Greengard and Feigelson, 1961; Schimke et al., 1965; Knox, 1966) . TDO is a tetrameric hemoprotein, containing 2 mol of heme 1 /mol of enzyme (Schutz and Feigelson, 1972) . In the liver, TDO is intimately associated with the "free" heme pool and normally exists partly saturated with heme and, thus, at half of its full functional potential (Greengard and Feigelson, 1961; Marver et al., 1966; Bissell and Hammaker, 1977) . Full functional activation occurs after saturation of all TDO prosthetic heme-binding sites by either in vivo heme administration to rats or in vitro hemin incubation of liver homogenates. Because TDO activity is modulated by the hepatic free-heme pool, pool size fluctuations markedly, albeit reversibly, influence TDO function, thereby modulating L-Trp and 5-HT turnover in the central nervous system and other serotonergic tissues Correia, 1983, 1985) .
Hepatic TDO is induced via glucocorticoid-mediated transcriptional activation and by substrate stabilization (Danesch et al., 1987; Nakamura et al., 1987) . We have reported that heme is required for both basal and dexamethasone (DEX)-inducible TDO expression and function (Ren and Correia, 2000) . Accordingly, in rats acutely depleted of hepatic heme by in vivo treatment with DDEP [3,5-dicarbethoxy-2,6-dimethyl-4-ethyl-1,4-dihydropyridine, a cytochrome P450 suicide inactivator that destroys the prosthetic heme by converting it into N-ethylprotoporphyrin(s), highly potent inhibitors of the heme synthetic enzyme ferrochelatase (De Matteis et al., 1980; Ortiz de Montellano et al., 1980 , 1981 ], both basal and DEX-mediated transcriptional activation of hepatic TDO was significantly (40 -50%) impaired as monitored by Northern analyses. This impairment was reversed by in vivo heme administration (Ren and Correia, 2000) . Run-on assays with hepatic nuclei isolated from these rats revealed that acute hepatic heme depletion markedly reduced the basal TDO transcriptional rates and that DEX treatment of these rats only partially restored these rates to those of DEX-treated controls. Full restoration was observed after in vivo hemin administration but not after inclusion of hemin in vitro in these assays, thereby indicating the importance of intrahepatic heme for this transcriptional process but excluding a direct effect of hemin. These findings thus suggested that heme may play a critical role in DEX-mediated induction of the TDO gene by interacting with a transcriptional activator or repressor.
As an initial approach to elucidation of the potential mechanism of such heme regulation, we examined the influence of heme on DEX-mediated expression of endogenous TDO mRNA and protein in primary cultured hepatocytes acutely depleted of heme. Our findings reveal that although heme regulates hepatic TDO expression, this regulation is at a posttranscriptional step through translational control by a hemesensitive hepatic eukaryotic initiation factor 2 ␣-subunit (eIF2␣) kinase (also known as heme-regulated inhibitor, HRI). Functional unleashing of this eIF2␣ kinase in heme deficiency results in the phosphorylation of the ␣-subunit of eIF2 (Chen et al., 1989 Pal et al., 1991; Crosby et al., 1994; Chen and London, 1995; Chen, 2006) and consequent global suppression of de novo syntheses of hepatic proteins, including TDO and CYP2B (Han et al., 2005) .
Given its critical importance in controlling hepatic protein synthesis in heme-deficient states and because the hemeregulated eIF2␣ kinase (HRI) has been claimed to be specific to erythroid cells and their progenitors Crosby et al., 1994; Chen and London, 1995) , we have successfully cloned the cDNA for this elusive eIF2␣ kinase from acutely heme-depleted intact rat livers and size-elutriated rat hepatocytes and, through DNA sequencing, found it to be identical to the previously cloned rat brain HRI cDNA (Mellor et al., 1994) . Our quantitative real-time PCR (qRT-PCR) analyses of mRNA isolated from acutely heme-depleted hepatocytes coupled with HRI-immunoblotting analyses of their lysate protein indicated that hepatic HRI transcriptional activation and/or content are unaffected by heme deficiency. Thus, the global suppression of protein synthesis observed in these heme-depleted hepatocytes is most probably due to the functional activation of an HRI enzyme and consequent enhancement of eIF2␣ phosphorylation. We have heterologously expressed the isolated full-length rat hepatic HRI cDNA and purified the recombinant protein to near homogeneity and immunoaffinity-purified the HRI protein from size-elutriated rat hepatocytes. Proteomic, immunoblotting, and/or biochemical analyses of the recombinant and native proteins unequivocally establish their functional identity as a rat hepatic heme-sensitive eIF2␣ kinase (HRI).
Materials and Methods

Materials.
Common cell culture medium and supplements such as Williams' Medium E (WME), insulin-transferrin-selenium-G (100ϫ), bovine serum albumin, penicillin/streptomycin, L-glutamine, liver digestion medium, and liver perfusion medium were obtained from Invitrogen Life Technologies (Carlsbad, CA). Methionine/cysteine-free WME was prepared by the University of California San Francisco (UCSF) Cell Culture Facility (San Francisco, CA). Collagen type I was prepared by the UCSF Liver Center Cell and Tissue Biology Core Facility. Matrigel was obtained from BD Biosciences (Bedford, MA). Petri dishes (60 mm, Permanox) were purchased from Nalge Nunc International (Rochester, NY). Phenylmethylsulfonyl fluoride, hemin 1 hydrochloride, and DEX were purchased from Sigma-Aldrich (St. Louis, MO). DDEP was synthesized as described previously Correia, 1983, 1985) . N-Methylprotoporphyrin IX (NMPP, a mixture of all four isomers) was purchased from Frontier Scientific Inc (Logan, UT). E-64, leupeptin, and aprotinin were purchased from Roche Applied Science (Indianapolis, IN). Dimethyl pimelimidate⅐2HCl was purchased from Pierce (Rockford, IL). [
35 S]EXPRESS methionine was purchased from PerkinElmer Life and Analytical Sciences (Boston, MA). Cloning reagents, such as restriction enzymes, ligases, and Vent polymerase, were obtained from New England BioLabs (Beverly, MA). Primers and probes were from IDT Inc. (Coralville, IA). Polyclonal antibodies against eIF2␣ and phosphospecific eIF2␣ (pS52) were purchased from BioSource Intel. Inc. (Camarillo, CA). Rabbit polyclonal IgGs were raised commercially against purified recombinant rat hepatic tryptophan 2,3-dioxygenase and eIF2␣ kinase (HRI) and purified by Hi-Trap Protein A-Sepharose affinity chromatography. Reagents for TaqMan analyses were obtained from ABI Prism (Foster City, CA).
Rat Hepatocyte Isolation. Male Sprague-Dawley rats (225-250 g) were purchased from Charles River (Wilmington, MA) and maintained on a 12-h light/dark cycle in a controlled environment at the UCSF Animal Care Facility. Hepatocytes were isolated from rats by in situ perfusion of the liver with collagenase and purified by centrifugal elutriation as described previously (Han et al., 2005) .
Endogenous TDO or HRI mRNA and Protein Expression. These were examined in primary rat hepatocytes cultured in a Matrigel-collagen type I sandwich exactly as described previously (Han et al., 2005) . In these experiments, DEX (0.1 M) is included throughout the cell culture to maintain P450 inducibility and function, required for DDEP-mediated inhibition of ferrochelatase and consequent hepatic heme depletion. Cells were allowed to recover for 72 h with a daily change of medium before initiation of any treatment. At 72 h, cells were treated with DDEP (10 M) to deplete heme, and at 84 h, DEX (5 M) was added along with DMSO (vehicle) or DDEP (10 M). Wherever indicated, hemin (20 M) was also included at 73 h, and all cells were harvested at 90 h. In most experiments, DDEP was replaced by NMPP (1 M). Total RNA was analyzed by qRT-PCR (TaqMan) analyses with a TDO or HRI-specific probe and rat ␤-glucuronidase (GUS) gene as the housekeeping control. Cell lysate protein was subjected to TDO-or HRI-immunoblotting analyses (Ren and Correia, 2000) .
Quantitative RT-PCR (TaqMan) Analyses. Total RNA was extracted with the QIAGEN RNeasy mini kit (Valencia, CA) and then reverse-transcribed to cDNA by Moloney murine leukemia virus reverse transcriptase (Invitrogen Life Technologies) exactly as described previously (Han et al., 2005) . Primers and probes for qRT-PCR analysis were designed with the Primer Express software (Version 2.0; Applied Biosystems, Foster City, CA). The TDO-specific primers were 5Ј-GGCTATTATTATCTGCGCTCAACTG-3Ј (forward) and 5Ј-GAACCAGGTACGATGAGAGGTTAAA-3Ј (reverse). The TDOspecific TaqMan probe was 5Ј-AGCGACAGGTACAAGGTGTTCGTG-GATT-3Ј. Amplification reactions were performed in a mixture (50 l) with final concentrations as follows: 1 ϫ TaqMan buffer, pH 8. , primers (900 nM), diethylpyrocarbonate-treated water, and cDNA (10 ng, based on the RNA concentration added to RT reaction). PCR was performed employing an ABI Prism TaqMan 7300 sequence detector system with denaturation at 95°C for 2 min, 40 cycles with denaturation at 95°C for 15 s, and annealing/extension at 60°C for 1 min (Han et al., 2005) . The expression level of each gene was normalized to the endogenous expression of the control gene (rat GUS) as described previously (Han et al., 2005) . Values are expressed as percentage of the value from nontreated hepatocytes.
qRT-PCR analyses of HRI were similarly conducted on RNA isolated from untreated DEX-and/or NMPP-treated Ϯ heme-treated cultured rat hepatocytes. Primers and probes were designed similarly for the detection of mRNA sequences for rat HRI and GUS. The HRI primers were 5Ј-CACTGCATGGATAGAGCACGTT-3Ј (forward) and 5Ј-GGGCAGTTGAATGGGAACTC-3Ј (reverse). The HRI-specific TaqMan probe was 5Ј-CGTGCTTCAGCCACAAG-3Ј. The 25 lreaction mixture for PCR was similar to the one above with the exception of the following: TaqMan Universal PCR buffer, 200 nM probes, 900 nM primers, and 25 ng of cDNA. PCR and data analyses were performed exactly as described above for the TDO gene and expressed relative to that of the untreated control value.
[ 35 S]Methionine/Cysteine Labeling of Cell Protein. Cells were cultured and labeled as described previously (Han et al., 2005) with modifications. In brief, cell cultures were treated with various chemicals for 23 h. The media were replaced with methionine/cysteine-free WME for 1 h and then pulsed with 50 Ci/ml [ 35 S]EX-PRESS for 1 h. Each 35 S-labeled culture was washed twice with ice-cold PBS containing methionine (0.2 mM) and cysteine (1.4 mM) and then lysed with 0.4 ml of HEPES buffer (20 mM), pH 7.5, containing 1% Triton X-100, NaCl (150 mM), 10% glycerol, EDTA (1 mM), NaF (100 mM), tetrabasic sodium pyrophosphate (10 mM), ␤-glycerophosphate (17.5 mM), phenylmethylsulfonyl fluoride (1 mM), leupeptin (2 M), aprotinin (0.04 U/ml), and E-64 (50 M). The lysate was sedimented at 10,000g at 4°C for 10 min, and the supernatant was saved for further study. To insure equivalent [
35 S] uptake into hepatocytes, the radioactivity of aliquots of the initial lysate was monitored in Ecolume (4 ml; ICN Biomedicals Inc., Costa Mesa, CA) by liquid scintillation spectrometry using a Beckman LS3801 liquid scintillation counter (Beckman Instruments, Fullerton, CA).
[ 35 S]TDO Immunoprecipitation. Rabbit anti-rat TDO IgGs (0.5 mg) were added to ice-cold PBS-equilibrated Protein A-Sepharose slurry (50 l) and then incubated at 4°C overnight to prepare the antibody-conjugated beads. Lysate protein (450 g) was adjusted to 2% SDS, boiled for 5 min, and diluted 1:4 (v/v), with Tris-HCl (50 mM, pH 7.4), Triton X-100 (2.5%, v/v), NaCl (190 mM), and EDTA (6 mM), and added to the antibody-conjugated beads. The mixture was then incubated at 4°C for 2 h with end-to-end rotation. The antigen/ antibody/Protein A-Sepharose complex was collected by centrifugation and washed five times with PBS containing 0.1% SDS and 0.5% Nonidet P-40. The antigen was eluted by heating the complex for 5 min in the sample loading buffer (80 l, 62.5 mM Tris-HCl, pH 6.8, 25% glycerol, 10% SDS, 5% ␤-mercaptoethanol, and 0.01% bromphenol blue). The radioactivity of a 10 l-aliquot was monitored in Ecolume (4 ml) by liquid scintillation spectrometry as described above.
Total Protein [ 35 S] Incorporation. Cold rat liver microsomal protein (6 -7 mg) was added as a protein carrier to 35 S-labeled cell lysate protein (1 mg), and the protein was precipitated with 5% H 2 SO 4 in methanol (v/v) followed by at the least five washes with the same solution. Pellets were then washed sequentially with organic solvents and dissolved exactly as described previously (Han et al., 2005) . Aliquots were used for determination of the protein concentration and specific radioactivity. Total 35 S protein incorporation was calculated as counts per min/milligram protein/hour.
Immunoblotting Analyses. Cultured hepatocytes were washed three times with ice-cold PBS before harvesting with "lysate" buffer (0.4 ml) consisting of Tris-HCl (20 mM, pH 7.5), NaCl (150 mM), Na 2 EDTA (1 mM), EGTA (1 mM), 1% Triton X-100, sodium pyrophosphate (2.5 mM), ␤-glycerophosphate (1 mM), Na 3 VO 4 (1 mM), protease inhibitors [leupeptin (4 M), pepstatin (3 M), aprotinin (1.3 inhibitory units/ml), antipain (3 M), 4-(2-aminoethyl)benzenesulfonyl fluoride (1 mM), bestatin (6 M), and E-64 (50 M)], 10% glycerol, and NaF (100 mM). The cell lysates were clarified by sedimentation at 10,000g for 10 min at 4°C, and the supernatants were stored at Ϫ80°C before immunoblotting analyses. TDO content was determined by Western immunoblotting analysis with rabbit polyclonal anti-rat TDO IgGs [1:7000 (v/v)] and a secondary goat antirabbit horseradish peroxidase (HRP)-coupled antibody [1:20,000 (v/ v)]. eIF2␣ and phosphorylated eIF2␣ (eIF2␣P) immunoblotting analyses were carried out exactly as described previously (Han et al., 2005) . Whereas the anti-human eIF2␣ IgGs recognize both phosphorylated and nonphosphorylated species of the protein, anti-human eIF2␣P IgGs recognize only the phosphorylated species. HRIimmunoblotting analysis was performed similarly using rabbit polyclonal IgGs [1:3000 (v/v)] raised against the recombinant intact rat hepatic HRI and purified by HiTrap Protein A affinity chromatography (Amersham Pharmacia Biotech, Little Chalfont, Buckinghamshire, UK), a secondary goat anti-rabbit HRP-coupled antibody [1:20,000 (v/v)], and Pierce SuperSignal detection system. Parallel immunoblotting analyses of actin in these lysates served as the loading control for normalization.
Cloning of a Rat Liver eIF2␣ Kinase (HRI) cDNA by RT-PCR. Total RNA was isolated from well perfused DDEP-treated rat livers or NMPP-treated cultured size-elutriated hepatocytes by the QIAGEN RNeasy Mini Kit as detailed previously (Han et al., 2005) and treated with DNase I to get rid of any possible trace DNA contamination. DNA-free RNA was used to synthesize eIF2␣ kinase cDNA by reverse transcription and PCR techniques using the primers 5Ј-AAC GAT GCT GGG GGG CGG CTC-3Ј (forward) and 5Ј-CCC TCT CAT CTC TTC AGC CCT TTG TCC TGC G-3Ј (reverse). The primers were based on the known rat brain HRI gene sequence (GenBank accession number NM013223) (Mellor et al.,1994) . The RT-PCR fragments were then cloned into pGEM-T Easy TA vectors and confirmed by DNA sequencing. The full-length rat hepatic HRI cDNA was sequenced twice from both directions. Site-directed mutagenesis was used to introduce an NdeI restriction enzyme site upstream of the HRI gene, and the full-length HRI cDNA was then cloned into pET28b vector, resulting in a plasmid encoding an HRI fusion protein with an N-terminal (His) 6 tag.
Expression and Purification of Recombinant HRI in Escherichia coli. This full-length (His) 6 HRI was expressed in E. coli BL21 cells. Bacterial culture was grown at 37°C to an OD 600 of 0.6 and then induced with 1 mM isopropyl ␤-D-thiogalactoside, and the temperature was then reduced to 15°C for 18 h. After induction, cells were harvested at the indicated times, suspended, and lysed by sonication in a 50 mM imidazole-containing buffer (300 mM NaCl, 50 mM NaH 2 PO 4 , pH 8.0). The 90,000-g supernatant was subjected to fast-performance liquid chromatography separation on a Ni 2ϩ -NTA-agarose column with a 50 to 500 mM imidazole concentration gradient. The protein eluting around Ϸ275 mM imidazole was dialyzed and stored at Ϫ80°C in PBS containing 10% glycerol. Protein purity was verified by SDS-PAGE. Fractions containing the purified HRI protein were pooled and concentrated by Amicon ultrafiltration. The identity of the purified protein was confirmed by LC-MS/MS of tryptic digests. A larger-scale purification of this protein with an additional size-exclusion chromatographic step for further purification was conducted for commercial polyclonal antibody generation in rabbits.
LC-MS/MS of Tryptic Digests. Aliquots of the purified recombinant HRI protein were reduced, alkylated with iodoacetamide, and digested with side-chain protected porcine trypsin (http:// ms-facility.ucsf.edu/ingel.html). To confirm the identity of the protein, an aliquot from this digest was subjected to LC-MS/MS analysis on a quadrupole-orthogonal acceleration-time-of-flight hybrid tandem mass spectrometer (QSTAR XL; MDS Sciex, Concord, ON, Canada) in an information-dependent fashion; one-second mass measurements were followed by 3-s collision-induced dissociation (CID) experiments on computer-selected multiply charged ions. The collision conditions were adjusted automatically to the mass and the charge state of the selected precursor. A database search (http:// prospector2.ucsf.edu) was performed with the acquired CID data against the SwissProt database. A mass accuracy of 200 and 300 ppm was considered for the precursor and fragment ions, respectively. Only tryptic peptides were accepted, and one missed cleavage was permitted. Cys carbamidomethylation was selected as a fixed modification, whereas the acetylation of protein N termini and Met oxidation and pyroglutamic acid formation from N-terminal Gln residues were considered as variable modifications. Peptides with probability scores of p Ͻ 0.05 were accepted.
Protein Kinase Assay. The purified recombinant HRI was functionally assayed for its ability to phosphorylate eIF2␣ as its substrate in vitro (Berlanga et al., 1998) . In a final volume of 20 l, the incubation reaction contained HRI (50 ng), purified recombinant eIF2␣ (500 ng) in 20 mM Tris buffer (pH 7.4) containing KCl (40 mM), magnesium acetate (3 mM), and DTT (1 mM). The reactions were initiated by the addition of 5 Ci of [␥-32 P]ATP (3000 Ci/mmol) and nonradioactive ATP (50 M), incubated at 30°C for 20 min, and terminated by the addition of SDS-sample buffer. Aliquots were subjected to 4 to 15% SDS-PAGE, and the gels quantitated by fluorography with phosphorimaging analyses.
Heme Sensitivity. Purified recombinant HRI was incubated with various concentrations of hemin (0 -5 M) at 30°C for 10 min as described above (Berlanga et al., 1998) . The relative sensitivity of eIF2␣ phosphorylation to each hemin concentration was assayed as described above.
Immunoaffinity Chromatographic Isolation of HRI Protein from Rat Hepatocytes. This was carried out by a modification of previously reported methods (Schneider et al., 1982; Chefalo et al., 1998) . Rabbit polyclonal anti-HRI IgG (20 mg), purified by HiTrap Protein A affinity chromatography, was incubated with PBS-equilibrated Protein A-Sepharose (3 mg/ml) by gentle end-to-end mixing for 2 h at room temperature and then washed extensively to remove unbound IgGs. The IgG-bound Protein A-Sepharose matrix was equilibrated with cross-linking buffer (0.1 M triethanolamine, pH 8.2) and then treated with gentle mixing with three sequential (5, Freshly isolated, size-elutriated, and/or Percoll gradient-purified rat hepatocytes (Ϸ120 ϫ 10 6 ) were washed in PBS and then lysed in the lysis buffer (Cell Signaling Technology Inc., Danvers, MA) supplemented with the additional protease inhibitors described above, as well as Triton X-100 and deoxycholate (DOC) to a final concentration of 2 and 1%, respectively. The mixture was allowed to stand on ice for 15 min before centrifugation at 20,000g for 30 min to remove insoluble cell debris. The supernatant was collected, adjusted to 0.3 M NaCl, and then precleared with PBS-equilibrated Protein A-Sepharose beads at 4°C with gentle rolling for 30 min, followed by recentrifugation at 20,000g for 30 min. The precleared cell lysate supernatant was then mixed with the PBS-equilibrated IgG-cross-linked Protein A-Sepharose beads with gentle mixing at 4°C for 4 h. The mixture was poured in a 20-ml glass column and then washed sequentially with i) 0.5 M NaCl, 0.05 M Tris-HCl, pH 8.2, 1 mM EDTA, and 0.5% Nonidet P-40; ii) 0.15 M NaCl, 0.05 M Tris-HCl, pH 8.2, 1 mM EDTA, 0.5% Nonidet P-40, and 0.1% SDS; iii) 0.15 M NaCl and 0.5% DOC; and iv) 0.15 M NaCl and 0.5% DOC. The bound HRI protein was then eluted sequentially with i) diethylamine (10 mM, pH 10.5), ii) triethylamine (10 mM, pH 11.5), and iii) triethylamine (100 mM, pH 11.5) in the presence of 10% glycerol and 0.5% DOC. The last step was repeated once. The eluates were collected and rapidly adjusted to pH 7.4 by the addition of Tris-HCl (1 M, pH 6.8) and concentrated with a Centricon 10 centrifugal device (Millipore Corporation, Billerica, MA), followed by three sequential washing dialyses steps with a Tris-HCl buffer (pH 7.8) containing 50 mM KCl, 0.1 mM EDTA, and 10% glycerol, the last step including additional DTT (2 mM) in the buffer. Each concentrated dialyzed eluate was supplemented with DTT (4 mM final) and stored in aliquots at Ϫ80°C until further analyses.
Aliquots of the initial rat hepatocyte lysate (RHL), the flowthrough (FT), and each of the four eluates termed E1, E2, E3, and E4 were subjected to SDS-PAGE analyses on 7.5% gels, as well as immunoblotting analyses with rabbit polyclonal anti-rat HRI IgGs [5.5 mg/ml; 1:3300 v/v in 3% nonfat milk-Tris-buffered saline containing 0.5% Tween-20], as the primary antibody and overnight incubation at room temperature with gentle rotation, followed by washes and secondary antibody [goat anti-rabbit HRP-coupled antibody (1:30,000, v/v) in 3% nonfat milk-Tris-buffered saline containing 0.5% Tween-20] for 1 h at room temperature, and detection with Pierce SuperSignal system. The eluate predominantly exhibiting a 76-kDa protein band after SDS-PAGE was subjected to proteomic analysis after slicing of the gel band, reduction, and alkylation with iodoacetamide, in situ tryptic digestion, and LC-MS/MS analyses of the tryptic digests as described above.
Analysis of the SDS-PAGE-Fractionated Proteins. Samples were in-gel-digested with trypsin (http://ms-facility.ucsf.edu/ ingel.html) and subjected to LC-MS/MS analysis as follows. Peptide fractionation was carried out on an 1100 nanoHPLC system (reversed phase, C18 column, 75 m ϫ 150 mm; flow rate ϳ300 nl/min; solvent A: 0.1% formic acid in water; solvent B: 0.1% formic acid in acetonitrile) (Agilent Technologies, Palo Alto, CA). The column was equilibrated with 2% B; 2 l of tryptic digests were injected and eluted with a gradient: 2 to 50% B over 48 min. Mass spectrometric data acquisition was performed on a hybrid linear ion trap-Fourier transform-ion cyclotron resonance mass spectrometer (Thermo, Bremen, Germany) equipped with a 7T ion cyclotron resonance magnet. Mass measurements and 10-Da zoom-in scans of the three most abundant ions were carried out in the FT; CID analyses of the same ions, if multiply charged, were performed in the ion trap; and dynamic exclusion was enabled.
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Peaklists were generated using Mascot Distiller version 2. Statistical Analyses. After statistical consultation, data were analyzed for statistically significant differences between control and treated rat hepatocyte cultures by the Student's t test at the 5% level of significance (Rothman, 1990 ) rather than adjusted for multiple comparisons. As discussed previously (Han et al., 2005) , the latter methods are controversial (Rothman, 1990; Bacchetti, 2002) because they require that the results of each analysis detract from the other. That is, each analysis is considered to be less believable than if it had been the only analysis. Because there are really only two primary comparisons of interest after NMPP-induced heme depletion [DEX versus DEX ϩ NMPP Ϯ heme], the extent of the multiplicity is relatively small.
Results
Effect of Heme on DEX-Inducible Endogenous TDO mRNA and Protein Expression. We examined the role of heme in DEX-inducible endogenous TDO mRNA and protein expression by qRT-PCR (TaqMan) and immunoblotting analyses, respectively, in primary hepatocytes cultured on type I collagen substratum with a Matrigel overlay that preserves many transcriptional functions, such as phenobarbital-induction of CYP2B (Han et al., 2005) . Because of DEX inclusion at plating, the basal levels of endogenous TDO mRNA expression were high and further increased 3 to 4-fold by DEX (5 M) induction. No significant effect on this DEX-inducible TDO mRNA expression was observed after DDEP-elicited heme depletion, nor was this mRNA expression affected by heme resupplementation (Fig. 1A) . As in intact rats (Ren and Correia, 2000) , immunoblotting analyses revealed the expected DEX-inducible increase of endogenous TDO protein that was significantly reduced by DDEP-elicited heme deficiency and restored to normal in these cells by heme resupplementation (Fig. 1B) .
To insure that these findings were unrelated to any chemical/oxidative stress-related effects of DDEP, we also examined the role of heme on endogenous TDO mRNA and protein expression in rat hepatocytes acutely depleted of heme by blockade with NMPP (1 M), a chemical analog of N-ethylprotoporphyrin(s), that is also a potent inhibitor of the heme synthetic enzyme ferrochelatase (De Matteis et al., 1980; Ortiz de Montellano et al., 1980 , 1981 . qRT-PCR (TaqMan) analyses of mRNA from untreated, DEX (5 M)-treated, DEX ϩ NMPP-treated, and DEX ϩ NMPP ϩ Heme-treated (20 M) cells with TDO-specific and GUS (internal control) primers and probes revealed the expected Ϸ20-fold DEXmediated induction of TDO mRNA, which remained essentially unaffected by either NMPP-induced inhibition of heme synthesis or further heme resupplementation ( Fig. 2A) . On the other hand, corresponding immunoblotting analyses of lysates from these treated cultures with TDO-specific polyclonal IgGs revealed the expected DEX-mediated induction of TDO protein that was significantly reduced by NMPPmediated blockade of heme synthesis (Fig. 2B) . Heme supplementation reversed this effect, restoring this reduced TDO protein content to DEX-inducible levels (Fig. 2B) . Together these findings suggested that, as in the case of DDEPinduced heme depletion, NMPP-induced heme depletion impaired TDO protein levels rather than TDO transcriptional activation. (Fig. 3, solid bars) , DEX increased the specific rate of [
Role of Heme on de Novo Synthesis of Total Hepatic and TDO-Specific
35 S]Met/Cys incorporation into TDO protein Ͼ15-fold. This was significantly attenuated after NMPP-induced heme depletion (Fig. 3) . Heme resupplementation of DEX/NMPPtreated cultures restored this rate nearly to DEX-inducible levels. In parallel, although DEX per se had no appreciable (Fig. 3, cross-hatched bars) to 3.6 Ϯ 0.7% of control (untreated) levels, whereas heme resupplementation of these NMPP/DEX-pretreated cultures restored the de novo synthesis of total hepatic protein to 102.8 Ϯ 10% (Fig. 3) . These findings thus indicate that hepatic heme depletion impairs both the de novo synthesis of TDO-specific and total hepatic protein. These effects were reversed by heme, thereby revealing a heme-dependent posttranscriptional control of several hepatic proteins, including TDO.
Effect of NMPP on eIF2␣ Phosphorylation. Parallel immunoblotting analyses of phosphorylated eIF2␣ and total eIF2␣ in corresponding cell lysates revealed that DEX treatment per se enhanced basal eIF2␣ phosphorylation slightly, albeit not statistically significantly, whereas NMPP treatment enhanced it Ϸ5-fold (Fig. 4) , whereas the combined NMPP/DEX treatment resulted in an additive effect that was largely attenuated by heme resupplementation to the levels of eIF2␣ phosphorylation observed with DEX treatment alone (Fig. 4) . As expected, these treatments failed to affect total hepatic eIF2␣ or actin (loading control) content (Fig. 4) . These findings thus indicate that the impairment of de novo hepatic TDO and total protein syntheses most probably results from translational control by a hepatic heme-sensitive eIF2␣ kinase.
Cloning of a Hepatic HRI cDNA from Intact Rat Liver and Cultured Primary Rat Hepatocytes. Previous studies to identify a hepatic eIF2␣ kinase in lysates from heme-depleted cultured rat hepatocytes with an antibody specific for the mouse eHRI had proved unsuccessful (J.-J. Chen, personal communication), leading us to suspect that rat HRI might be a distinct hepatic eIF2␣ kinase isoform. However, Northern analyses using a rat brain HRI cDNA probe had previously revealed appreciable HRI mRNA in adult rat liver (Mellor et al., 1994) . Given this evidence, as a first approach toward identifying a rat hepatic eIF2␣ kinase and probing its role in the translational control of hepatic proteins in heme deficiency, we chose to clone its cDNA from total mRNA isolated from perfused acutely heme-deficient rat livers. To exclude any possible erythroid RNA con- Fig. 2 . Effects of NMPP-induced heme depletion on endogenous TDO mRNA and protein expression. Hepatocytes were plated on collagen I with 0.1 M DEX, overlaid with Matrigel 2 h later, and allowed to recover for 72 h with daily change of medium in the absence of DEX. At 72 h, cells were treated with NMPP (1 M) to inhibit heme synthesis. At 73 h, DMSO (vehicle) or hemin (20 M) was added. DEX (5 M) was added 6 h before cell harvesting at 90 h. A, total RNA was analyzed by qRT-PCR (TaqMan) analyses with a TDO gene and GUS gene (as the internal control)-specific primers and probes. TDO mRNA values are expressed relative to control (untreated cell) value. B, lysate protein (10 g) from each cell culture was subjected to TDO-immunoblotting analyses as detailed and densitometrically quantified (Ren and Correia, 2000) . Parallel actin immunoblots are included as loading controls. For experimental details see Materials and Methods. Values are mean Ϯ S.D. of three individual cell cultures. Asterisks indicate statistically significant differences between the two indicated values at p Ͻ 0.001. NS, nonstatistically significant differences between the two indicated values. tamination of the perfused rat liver mRNA, we also cloned HRI cDNA using mRNA isolated from size-elutriated cultured rat hepatocytes treated with NMPP. Our findings revealed that not only was the rat liver HRI cDNA from both of these sources 100% identical to the previously reported rat brain HRI cDNA sequence (Q642C7/Q63185; Swiss-protein/TrEMBL database) but also that the HRI gene was indeed detectably transcribed into mRNA in the rat liver.
Heterologous Expression, Purification, Identification, and Functional Characterization of Rat Hepatic HRI. The N-terminally (His) 6 -tagged HRI was expressed in E. coli BL21 cells and purified on a Ni 2ϩ -NTA-agarose column. SDS-PAGE analysis of the purified protein eluting around Ϸ275 mM imidazole revealed Ϸ95% purity, with one predominant band of molecular mass of Ϸ76 kDa (Fig. 5) . This purified recombinant HRI was subjected to SDS-PAGE and in situ tryptic digestion followed by LC-MS/MS analyses and database mining. These analyses revealed the presence of 34 of the 44 theoretical tryptic peptides, including the C-terminal 26 residues of rat brain eIF2␣ kinase (sequence Q642C7/Q63185) (Mellor et al., 1994) in the tryptic digest of this protein, thereby confirming its identity as rat liver HRI.
The purified recombinant protein was functionally authenticated by its in vitro eIF2␣ kinase activity and its hemin sensitivity. SDS-PAGE followed by fluorography of the eIF2␣ kinase reactions in the presence of 0 to 5 M hemin revealed a concentration-dependent reduction of phosphorylated eIF2␣ band at 36 kDa (Fig. 6A) , with an IC 50 of 0.65 M, consistent with its well recognized hemin sensitivity (Fig.  6B) . Furthermore, as expected, a parallel hemin-mediated inhibition of HRI autophosphorylation was observed during this process, as determined by the progressive concentrationdependent reduction of phosphorylated Ϸ76-kDa band. Together, these findings document that the purified recombinant protein is a bona fide heme-sensitive eIF2␣ kinase.
Effects of NMPP-Induced Acute Hepatic Heme Depletion on HRI mRNA Expression. Given the notion that HRI is highly erythroid specific Crosby et al., 1994; Chen and London, 1995) , our finding of easily detectable HRI mRNA in heme-depleted rat livers and rat hepatocytes suggested the possibility that it was induced only after acute hepatic heme depletion. Therefore, we analyzed RNA isolated from untreated, DEX-treated, NMPP-treated, and DEX/NMPP Ϯ heme-treated cultured rat hepatocytes by qRT-PCR analyses (Fig. 7A ). These analyses of rat liver mRNA revealed significant expression of hepatic HRI gene in all groups of cultured hepatocytes. While definitively establishing the existence of a rat liver HRI mRNA, this expression was comparable in all hepatocyte cultures irrespective of treatment. These findings indicated that the increased eIF2␣ phosphorylation after heme depletion was not due to its transcriptional activation but most likely due to differential post-transcriptional, translational, and/or posttranslational functional activation of HRI.
Effects of Heme Depletion on Relative Hepatic HRI Protein Content. Given the above results, we also considered the alternative possibility that acute hepatic heme depletion induced HRI expression at the protein rather than mRNA stage. Thus, the endogenous HRI protein expression was examined by immunoblotting analyses of lysates from (Fig. 7B) . Contrary to the previous reports in mouse and/or rabbit liver Crosby et al., 1994; Chen and London, 1995) , these analyses with rabbit polyclonal anti-HRI IgGs clearly revealed abundant HRI in rat hepatocytes (Fig. 7B) . However, no significant differences in HRI protein content were observed between any of these cultures. Similar analyses of cultured rat hepatocyte lysate with rabbit preimmune IgGs yielded no corresponding signal at 76 kDa (Fig. 7C) , thereby excluding the possibility that this immunochemical detection of rat hepatic HRI was due to nonspecific reactivity. Together these findings on HRI mRNA and protein expression clearly indicate that acute hepatic heme deficiency does not affect rat hepatic HRI transcriptionally or translationally. Given its documented heme sensitivity, collectively these findings reveal that acute hepatic heme depletion results in the functional activation of HRI and consequently increased eIF2␣ phosphorylation. Immunoaffinity Capture of HRI Protein from Rat Hepatocytes. To unequivocally establish its presence, rat hepatic HRI was isolated by immunoaffinity chromatography of lysates from size-fractionated rat hepatocytes as described under Materials and Methods). The hepatic lysate along with its flow-through fraction and the E1, E2, E3, and E4 eluates from the anti-HRI IgG-cross-linked Protein A-Sepharose beads were collected and subjected to SDS-PAGE analyses on 7.5% gels as well as immunoblotting analyses with rabbit polyclonal anti-HRI IgGs as described above (Fig. 8) . SDS-PAGE analysis of the eluates revealed that E3, eluted with 0.1 M triethylamine (pH 11.5), contained the major fraction of a hepatic protein that electrophoretically migrated around 76 kDa (Fig. 8A) . Considerably lesser amounts of this protein were detected in E1 and E2 eluates (Fig. 8A) , and none was detected in the E4 (data not shown), thereby suggesting that most of the bound protein was eluted with the first round of 0.1 M triethylamine (pH 11.5). That this Ϸ76-kDa hepatic protein was indeed HRI was established not only by parallel immunoblotting analyses (Fig. 8B ) but also by proteomic analyses of the 76-kDa protein band. Thus, consistent with the presence of HRI in the rat liver, the initial lysates of rat hepatocytes contained detectable HRI protein that was absent in the corresponding flow-through of the anti-HRI IgG-cross-linked Protein A-Sepharose column after initial passage of the lysate. That the HRI protein had indeed been sequestered from the lysate was verified by immunoblotting analyses of the four eluates that documented that HRI was sequentially eluted with the major fraction present in E3 and none in E4. More importantly, LC-MS/MS analyses of the in situ trypsin-digested 76-kDa protein band after SDS-PAGE of the E3 eluate (Fig. 8A) indicated the unambiguous presence of rat hepatic HRI protein, confirmed from 30 tryptic peptides with 48% sequence coverage (Q63185/Q642C7; see supplementary data), versus 34 tryptic peptides with a corresponding 54% sequence coverage for the recombinant hepatic HRI analyzed as the control. The detection of IgG-derived peptides as minor contaminants in the tryptic digests of the 76-kDa protein after proteomic analyses indicated that the highly alkaline elution buffers also leached out some cross-linked anti-HRI IgG, clearly detectable as a 55-kDa protein band after SDS-PAGE. Collectively, these findings unambiguously establish the existence of a rat hepatic HRI.
Discussion
To determine whether acute hepatic heme depletion impairs DEX-mediated TDO induction through defective mRNA transcription (Ren and Correia, 2000) , we examined this process in a more defined and controllable system: primary rat hepatocytes cultured in a collagen-Matrigel "sandwich". This system, expected to more competently preserve transcription factors, revealed no specific effects of heme depletion and/or repletion on DEX-mediated transcriptional activation of the endogenous TDO mRNA. These findings in cultured hepatocytes thus differ from those in intact rats 2 (Ren and Correia, 2000) . Nevertheless, in both models, hepatic heme depletion definitely reduced DEX-inducible hepatic TDO protein content, an effect abrogated by heme resupplementation. More importantly, our findings in cultured hepatocytes indicate that heme regulates TDO gene expression not transcriptionally but rather post-transcriptionally. Such posttranscriptional regulation could entail translational control as well as enhanced proteolytic degradation of the heme-denuded TDO apoprotein as discussed previously (Ren and Correia, 2000) . Indeed, our findings in heme-depleted hepatocytes that the de novo syntheses of TDO and total protein was blocked and that this blockade was associated with enhanced eIF2␣ phosphorylation in a heme-reversible manner implicated a heme-sensitive hepatic eIF2␣ kinase in this translational regulation.
Such eIF2␣ kinase-mediated translational control is exerted via Ser51 phosphorylation of the ␣-subunit of the eIF2. This in turn results in the sequestration of eIF2B, the exchange factor required for eIF2 recycling between the inactive GDP-bound species (released after GTP hydrolysis before protein chain elongation) and the active GTP-bound species critical for each fresh cycle of translational initiation. To date, four different eIF2␣ kinases have been identified: i) eHRI (EIF2AK1), the erythroid heme-regulated inhibitor, activated by heme deficiency and oxidative and heat stresses in reticulocytes and fetal liver erythroid progenitors (Chen, 2006) ; ii) PKR (RNA-dependent protein kinase), an interferon-inducible antiviral defense mechanism (EIF2AK2) (Wek et al., 2006) ; iii) pancreatic eIF2␣ kinase or PERK [PKR-like endoplasmic reticulum (ER)-bound eIF2␣-kinase (EIF2AK3)] (Harding et al., 2003; Kaufman, 2004) induced by ER-stress and unfolded protein response (UPR); and iv) GCN2 (general control nonderepressible-2 or EIF2AK4) induced by amino acid deprivation and non-nutritional stresses such as UV irradiation and proteasome inhibition (Kimball and Jefferson, 2004; Wek et al., 2006) . Of these, GCN2 and PKR may be excluded a priori because they neither contain "heme-regulatory motifs" nor are they "heme-sensitive". Their exclusion is also justified because the cultured hepatocytes were adequately supplied with essential amino acids and thus were neither "amino acid-starved" nor exposed to any identifiable interferon-inducing agents. We (Han et al., 2005) have previously excluded PERK, the ER eIF2␣ kinase activated by various ER-stresses such as UPR, protein misfolding, and hypoxia on grounds of no detectably increased cellular con- Fig. 8 . SDS-PAGE and immunoblotting analyses of immunoaffinity-isolated HRI from freshly isolated, size-fractionated rat hepatocytes. A, SDS-PAGE analyses with colloidal Coomassie Brilliant Blue staining of the initial lysates (RHL, 60 g) from size-fractionated 120 ϫ 10 6 rat hepatocytes; the corresponding FT fraction (60 g) and eluates E1, E2, and E3 (15 g) are shown along with the purified recombinant HRI protein (2 g) and molecular weight (MW) standards. E3* eluate from a repeat experiment using lysates from size-fractionated 45 ϫ 10 6 hepatocytes is also included. For experimental details, see Materials and Methods. Proteomic analyses of the E3 lane reveal that the protein band at 76 kDa predominantly contains the HRI protein with minor IgG contaminants, whereas the ones at 150 and Ϸ185 kDa contain some HRI as well as rabbit IgG leached from the immunoaffinity matrix. B, immunoblotting analyses of RHL (80 g), FT (80 g), and E1, E2, E3, and E4 fractions (6 g each) along with recombinant HRI (0.4 g) as described under Materials and Methods.
Hepatic HRI Activation in Acute Heme Deficiency 987 at ASPET Journals on November 4, 2017 jpet.aspetjournals.org tacks apparently ensue from disruption of signaling pathways in acutely heme-deficient neuronal cells (Mense and Zhang, 2006) . Acute hepatic heme depletion reduces TDO function, impairs L-Trp catabolism, and alters the serotonergic tone in the central nervous system, thereby also possibly contributing to these neurological symptoms Correia, 1983, 1985) . Our current findings suggest that acute hepatic heme deficiency through activation of a heme-sensitive eIF2␣ kinase can shut off the synthesis of myriad intracellular proteins, including hemoproteins. Similar translational suppression of other short-lived hepatic proteins could similarly affect various vital homeostatic functions and/or alter the flux of additional neuroactive amino acids, thereby also contributing to the panoply of clinical symptoms observed in these acute heme-deficient states.
